S.A. Cederholm-Williams

2.2k total citations
51 papers, 936 citations indexed

About

S.A. Cederholm-Williams is a scholar working on Cancer Research, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S.A. Cederholm-Williams has authored 51 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 17 papers in Hematology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S.A. Cederholm-Williams's work include Protease and Inhibitor Mechanisms (22 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Blood properties and coagulation (12 papers). S.A. Cederholm-Williams is often cited by papers focused on Protease and Inhibitor Mechanisms (22 papers), Blood Coagulation and Thrombosis Mechanisms (14 papers) and Blood properties and coagulation (12 papers). S.A. Cederholm-Williams collaborates with scholars based in United Kingdom, Belgium and Switzerland. S.A. Cederholm-Williams's co-authors include Désiré Collen, F De Cock, Henri Roger Lijnen, Susan Burge, M.J. Allington, Chris P. Ponting, John Marshall, Margaret Rees, Charles S. Cockell and Keith M. Dawson and has published in prestigious journals such as Biochemical Journal, FEBS Letters and The American Journal of Cardiology.

In The Last Decade

S.A. Cederholm-Williams

46 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.A. Cederholm-Williams United Kingdom 18 290 252 184 181 123 51 936
R. L. Priore United States 17 206 0.7× 217 0.9× 269 1.5× 232 1.3× 102 0.8× 30 1.1k
L. de Lumley France 20 73 0.3× 300 1.2× 173 0.9× 176 1.0× 63 0.5× 45 1.0k
Philippe Moulin Belgium 19 67 0.2× 285 1.1× 135 0.7× 252 1.4× 59 0.5× 46 935
MA Blajchman Canada 17 147 0.5× 832 3.3× 150 0.8× 171 0.9× 74 0.6× 38 1.6k
Noreen Gleeson Ireland 24 420 1.4× 142 0.6× 157 0.9× 454 2.5× 165 1.3× 103 1.9k
M. R. Moore United States 16 137 0.5× 97 0.4× 287 1.6× 181 1.0× 36 0.3× 41 1.1k
Martine George United States 9 101 0.3× 179 0.7× 298 1.6× 120 0.7× 17 0.1× 16 898
L. Laterveer Netherlands 15 113 0.4× 648 2.6× 98 0.5× 244 1.3× 91 0.7× 19 1.3k
Iuliana Shapira United States 20 442 1.5× 133 0.5× 247 1.3× 244 1.3× 179 1.5× 53 1.6k
Jun Ah Lee South Korea 22 132 0.5× 95 0.4× 543 3.0× 236 1.3× 127 1.0× 84 1.3k

Countries citing papers authored by S.A. Cederholm-Williams

Since Specialization
Citations

This map shows the geographic impact of S.A. Cederholm-Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.A. Cederholm-Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.A. Cederholm-Williams more than expected).

Fields of papers citing papers by S.A. Cederholm-Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.A. Cederholm-Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.A. Cederholm-Williams. The network helps show where S.A. Cederholm-Williams may publish in the future.

Co-authorship network of co-authors of S.A. Cederholm-Williams

This figure shows the co-authorship network connecting the top 25 collaborators of S.A. Cederholm-Williams. A scholar is included among the top collaborators of S.A. Cederholm-Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.A. Cederholm-Williams. S.A. Cederholm-Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skok, Maryna, et al.. (2006). [The role of fibrin clot degradation products in the regulation of vital functions of PC-12 cells].. PubMed. 77(5). 37–44. 1 indexed citations
2.
Quarmby, John, Alberto Smith, Michael P. Collins, S.A. Cederholm-Williams, & K G Burnand. (1999). A model of in vivo human venous thrombosis that confirms changes in the release of specific soluble cell adhesion molecules in experimental venous thrombogenesis. Journal of Vascular Surgery. 30(1). 139–147. 27 indexed citations
3.
Elliott, John, D. Cross, S.A. Cederholm-Williams, & Harvey D. White. (1993). Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy. The American Journal of Cardiology. 71(8). 640–645. 48 indexed citations
4.
Stevens, Julian D., John Marshall, Laércio A. Benjamin, S.A. Cederholm-Williams, & Anthony J. Bron. (1992). Plasminogen activator in human tears. Eye. 6(6). 653–658. 6 indexed citations
5.
Burge, Susan, John Marshall, & S.A. Cederholm-Williams. (1992). Plasminogen binding sites in normal human skin. British Journal of Dermatology. 126(1). 35–41. 33 indexed citations
6.
Burge, Susan, S.A. Cederholm-Williams, David R. Garrod, & T. J. Ryan. (1991). Cell adhesion in Hailey–Hailey disease and Darier's disease: immunocytological and explant-tissue-culture studies. British Journal of Dermatology. 125(5). 426–435. 24 indexed citations
7.
Kennedy, Stephen, et al.. (1989). Cardiolipin antibody levels in endometriosis and systemic lupus erythematosus. Fertility and Sterility. 52(6). 1061–1062. 20 indexed citations
8.
Marshall, John, et al.. (1988). Effect of bradykinin on the exposure of tissue plasminogen activator from human endothelial cells. Fibrinolysis and Proteolysis. 2(2). 107–110. 3 indexed citations
9.
Ng, Y C, D K Peters, S.A. Cederholm-Williams, & Mark Walport. (1987). A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).. PubMed. 69(1). 89–97. 9 indexed citations
10.
Easty, D M, G C Easty, Antonio Baici, et al.. (1986). Biological studies of ten human squamous carcinoma cell lines: An overview. European Journal of Cancer and Clinical Oncology. 22(6). 617–634. 15 indexed citations
11.
Cederholm-Williams, S.A., Margaret Rees, & A. C. Turnbull. (1984). Examination of Certain Coagulation Factors in Menstrual Fluid from Women with Normal Blood Loss. Thrombosis and Haemostasis. 52(3). 224–225. 4 indexed citations
12.
Smith, Maggie, et al.. (1983). Influence of pre-eclampsia on concentrations of haemostatic factors in mothers and infants.. Archives of Disease in Childhood. 58(9). 739–741. 5 indexed citations
13.
Cederholm-Williams, S.A., et al.. (1981). Plasma levels of selected haemostatic factors in newborn babies. Thrombosis Research. 23(6). 555–558. 10 indexed citations
14.
Cederholm-Williams, S.A., et al.. (1981). Binding of plasmin(ogen) to sepharose bound fibrin(ogen) alpha-chain. Thrombosis Research. 21(4-5). 503–506. 5 indexed citations
15.
Cederholm-Williams, S.A.. (1981). The effect of streptokinase on the fibrin binding site of plasmin(ogen). Thrombosis Research. 21(6). 649–654. 11 indexed citations
16.
Cederholm-Williams, S.A., Timothy Dornan, & R. C. Turner. (1981). The metabolism of fibrinogen and plasminogen related to diabetic retinopathy in man. European Journal of Clinical Investigation. 11(2). 133–138. 12 indexed citations
17.
Cederholm-Williams, S.A.. (1980). The binding of plasmin-streptokinase complex to fibrin monomer-sepharose. Thrombosis Research. 17(3-4). 573–576. 2 indexed citations
18.
Cederholm-Williams, S.A., et al.. (1979). The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen) - fibrin complexes. Thrombosis Research. 16(5-6). 705–713. 18 indexed citations
19.
Mishler, John Milton, J. H. Darley, S.A. Cederholm-Williams, & G. Wright. (1978). Whole blood storage in citrate and phosphate solutions containing half‐strength trisodium citrate: Cellular and biochemical studies. The Journal of Pathology. 124(3). 125–139. 3 indexed citations
20.
Chesterman, C.N., S.A. Cederholm-Williams, M.J. Allington, & A. A. Sharp. (1977). The formation of a fibrinogen-activator complex by the action of streptokinase. Thrombosis Research. 10(3). 421–430. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. L. Priore Breakdown of academic impact, for papers by L. de Lumley Breakdown of academic impact, for papers by Philippe Moulin Breakdown of academic impact, for papers by MA Blajchman Breakdown of academic impact, for papers by Noreen Gleeson Breakdown of academic impact, for papers by M. R. Moore Breakdown of academic impact, for papers by Martine George Breakdown of academic impact, for papers by L. Laterveer Breakdown of academic impact, for papers by Iuliana Shapira Breakdown of academic impact, for papers by Jun Ah Lee
Rankless by CCL
2026